Tag: nasdaq:ntgn

September 8, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Abeona Rises 66 Percent

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
April 8, 2019

Neon Therapeutics Completes Enrollment in Phase 1b NT-002 Clinical Trial for Metastatic Non-Small Cell Lung Cancer

Neon Therapeutics (NASDAQ:NTGN) has announced it has completed enrollment of NT-002, its Phase 1b clinical trial evaluating NEO-PV-01 with KEYTRUDA...
October 22, 2018

8 Top Gains and Losses at 2018’s ESMO Event

Big Pharma players and smaller oncology-focused companies alike were among the presenters at the annual meeting, which runs from October...
June 27, 2018

Neon Therapeutics Announces Pricing of Initial Public Offerings

Neon Therapeutics (Nasdaq:NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced the pricing of its initial public offering of 6,250,000...